Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F7UD9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,326
Award facts
- Contract value 100% obligated
- $13,325.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,325.79 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/ml packaging. The contract is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and represents no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award reflects AmerisourceBergen Drug Corp's established capability to fulfill federal medical supply requirements through open competition and positions the contractor within the DLA's strategic Pharmaceutical Prime Vendor Global Program framework.
Quick answers
Who was awarded contract SPE2DR26F7UD9?
SPE2DR26F7UD9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26F7UD9 worth?
The government has obligated $13,326 on SPE2DR26F7UD9.
Is contract SPE2DR26F7UD9 an order under another contract?
Yes. SPE2DR26F7UD9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UD9 competed?
The extent of competition for SPE2DR26F7UD9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award